Live news related to NANOBIOTIX stock (FR0011341205): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on NANOBIOTIX mainly cover share price moves, analyst notes et M&A activity. The stock trades at €35,04 on Euronext Paris, up 1,15% at the last update. This page lists the articles published on NANOBIOTIX stock to track the share price, company announcements and any item likely to influence market perception.
The French biotech company records a second session of strong gains, positioning itself at the forefront of the broad Paris index. The rebound follows…
The French biotech company marks a new surge in early afternoon, taking the lead in the broad Paris index. The stock has moved back above its short-te…
French biotech company Nanobiotix pauses this Wednesday after several sessions of strong gains. The stock is among the most notable declines in the SB…
This Friday morning, the French biotech company sees another surge, driven by a target price upgrade from an analysis firm. The stock crosses a closel…
The French biotech continues its recovery in late afternoon trading, in a Parisian market distinctly on the rise. The stock continues to widen the gap…
The French biotech extends its recovery as the market close approaches, going against the grain of a Parisian market heavily penalized by the new mili…
The French biotech company marks another session of strong gains, positioning itself among the top performers on the broad Paris index. The rebound co…
The French biotech firm is regaining momentum this late morning, after several sessions marked by the digestion of its annual rally. The stock is amon…
The French biotech company is experiencing another downturn in a Parisian market that is also trending downward. The stock continues its consolidation…
The French biotech continues another session of decline in a Parisian market also trending downward. The stock extends the consolidation phase that be…
